
Boligra-M Tablet
Marketer
Bolivian Healthcare
Salt Composition
Montelukast (10mg) + Fexofenadine (120mg)
Overview Boligra-M Tablet
Aller-Comb tablets combine medications to alleviate allergy symptoms like nasal discharge, nasal congestion, sneezing, lacrimation, and sinus pressure. Dosage and treatment duration for Aller-Comb should follow your physician's instructions, varying based on individual response and condition severity. Continue the prescribed course; premature discontinuation may lead to symptom recurrence and condition exacerbation. Disclose all other medications to your healthcare provider, as interactions are possible. Common side effects, such as nausea, diarrhea, vomiting, rash, influenza-like symptoms, and headache, are typically transient. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid driving or activities demanding concentration until the drug's impact is known. Alcohol consumption should be avoided due to potential increased drowsiness. Self-medication and sharing medication are strongly discouraged. Adequate hydration is recommended. Prior to commencing treatment, inform your doctor about any liver or kidney conditions, pregnancy, pregnancy plans, or breastfeeding.
Uses of Boligra-M Tablet
Allergic rhinitis management: addressing sneezing and nasal discharge.
Major Benefits of Boligra-M Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Boligra-M Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
Common Side effects of Boligra-M Tablet:
- Nausea
- Diarrhea
- Vomiting
- Flu-like symptoms
- Headache
- Drowsiness
- Dizziness
- Upper respiratory tract infection
- Increased transaminase level in blood
- Fever
- Skin rash
How to use Boligra-M Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Boligra-M Tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
How Boligra-M Tablet works:
Montelukast, a leukotriene receptor inhibitor, counteracts the effects of leukotrienes, inflammatory chemicals. This action diminishes airway and nasal inflammation, alleviating related symptoms. Fexofenadine, an antihistamine, neutralizes histamine, another inflammatory mediator, thereby mitigating allergic responses such as rhinorrhea, lacrimation, and sneezing.
SAFETY ADVICE
KidneyCAUTION
Patients with kidney impairment should use Boligra-M Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Severe drowsiness may occur in those with end-stage renal disease.
LiverSAFE IF PRESCRIBED
Use of Boligra-M Tablet in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Boligra-M Tablet :
Should you forget a Boligra-M Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Boligra-M Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Breathing |
